Back to Search
JILLIAN GRAFF, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1932787215Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
PMID 18245460·Cancer Res·2008
6-review
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.
PMID 17382720·J Urol·2007
3-trial
Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs.
PMID 12741684·Clin Exp Metastasis·2003
6-review
Disassociation of carbon disulfide-induced depression of flash-evoked potential peak N166 amplitude and norepinephrine levels.
PMID 12700426·Toxicol Sci·2003
7-preclinical
Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma.
PMID 11901476·Expert Opin Ther Targets·2002
6-review
Integrin-linked kinase expression increases with prostate tumor grade.
PMID 11448915·Clin Cancer Res·2001
8-other
Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
PMID 11751475·Clin Cancer Res·2001
4-observational
Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression.
PMID 10644736·J Biol Chem·2000
8-other
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
PMID 19373123·Pharmacogenet Genomics·2009
8-other
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study.
PMID 18800232·Eur J Health Econ·2009
8-other
Prevalence of developmental and behavioral disorders in a pediatric hospital.
PMID 19254983·Pediatrics·2009
8-other
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism.
PMID 19180189·PLoS Pathog·2009
7-preclinical
Polysaccharides derived from Yamoa (Funtumia elastica) prime gammadelta T cells in vitro and enhance innate immune responses in vivo.
PMID 19671448·Int Immunopharmacol·2009
4-observational
In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography.
PMID 19503801·J Oncol·2009
8-other
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
PMID 19002764·Cancer Causes Control·2009
8-other
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
PMID 19383915·Cancer Res·2009
8-other
Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo.
PMID 18809571·Mol Cell Biol·2008
7-preclinical
White fat progenitor cells reside in the adipose vasculature.
PMID 18801968·Science·2008
7-preclinical
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
PMID 18753189·J Antimicrob Chemother·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2131 S 17TH ST
WILMINGTON, NC 28401 - Phone
- (910) 343-7000
Quick Facts
- NPI
- 1932787215
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile